• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. The True Story and Advantages of RNA Phage Capsids as Nanotools.
 

The True Story and Advantages of RNA Phage Capsids as Nanotools.

Options
  • Details
BORIS DOI
10.7892/boris.94914
Date of Publication
2016
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Author
Pumpens, Paul
Renhofa, Regina
Dishlers, Andris
Kozlovska, Tatjana
Ose, Velta
Pushko, Peter
Tars, Kaspars
Grens, Elmars
Bachmann, Martin
Universitätsklinik für Rheumatologie, Immunologie und Allergologie, Fachbereich Immunologie
Subject(s)

600 - Technology::610...

Series
Intervirology
ISSN or ISBN (if monograph)
0300-5526
Publisher
Karger
Language
English
Publisher DOI
10.1159/000449503
PubMed ID
27829245
Description
RNA phages are often used as prototypes for modern recombinant virus-like particle (VLP) technologies. Icosahedral RNA phage VLPs can be formed from coat proteins (CPs) and are efficiently produced in bacteria and yeast. Both genetic fusion and chemical coupling have been successfully used for the production of numerous chimeras based on RNA phage VLPs. In this review, we describe advances in RNA phage VLP technology along with the history of the Leviviridae family, including its taxonomical organization, genomic structure, and important role in the development of molecular biology. Comparative 3D structures of different RNA phage VLPs are used to explain the level of VLP tolerance to foreign elements displayed on VLP surfaces. We also summarize data that demonstrate the ability of CPs to tolerate different organic (peptides, oligonucleotides, and carbohydrates) and inorganic (metal ions) compounds either chemically coupled or noncovalently added to the outer and/or inner surfaces of VLPs. Finally, we present lists of nanotechnological RNA phage VLP applications, such as experimental vaccines constructed by genetic fusion and chemical coupling methodologies, nanocontainers for targeted drug delivery, and bioimaging tools.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/149459
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
449503.pdftextAdobe PDF949.32 KBpublisherpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: b407eb [23.05. 15:47]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo